Matches in SemOpenAlex for { <https://semopenalex.org/work/W1504722631> ?p ?o ?g. }
- W1504722631 abstract "Although rare in chronic phase myeloid leukemia (CML), primary or acquired resistance to the treatment with tyrosine kinase inhibitors (TKI) may be observed in the advanced phases of disease. Bcr/Abl related resistance has been well described, while the other mechanisms of resistance are poorly understood. In this study, we investigated the role of two SH2-containing, non-receptor protein tyrosine phosphatases (Shp1 and Shp2) in the resistance to Imatinib (Ima). To this aim, we have first used, as model system, a couple of Ima-sensitive (KCL22s) and Ima-resistant (KCL22r) KCL22 cell lines. In these cells, Ima resistance is independent by the oncogenic Bcr/Abl activity. We have found a very low level of Shp1 (both mRNA and protein), a protein with a tumour suppressor activity, in the KCL22r resistant cells, when compared to KCL22s sensitive cells. We have al shown the down-regulation of this gene to be related to the methylation level of SHP1 promoter. Indeed, 5-Azacytidine (5-AC) treatment, along with demethylation of the promoter region, re-induced expression of Shp1 in KCL22r. That treatment also re-established the Ima sensitivity, i.e. Ima growth inhibition, in these cells. At molecular level, the restored Ima sensitivity was associated to a significant reduction of phosphorylation of both STAT3 and ERK1/2. To better understand the functional role of Shp1, we carried out mass spectrometry to search for Shp1-binding proteins, and found that Shp1 interacts in these cells with Shp2, a protein phosphatase well known as positive regulator of oncogenic pathways, including the Ras/MAPK pathway. Gain-of-function mutations have been described in various hemopoietic neoplasias including Juvenile Chronic Myelomonocytic Leukemia. In Ph+ cells, oncogenic Bcr/Abl protein activates Shp2 through Gab2, an adaptor protein that, once phosphorylated is able to bind SH2 domain of Shp2. Through complex interactions that may involve the two carboxy-terminal tyrosine residues (542 and 580) Shp2 is also a signal transducer of growth factor receptor. We hypothesized that, Shp1, through dephosphorylation, might modulate the activity of Shp2 and constitute an important mechanism of Ima resistance. Knock-down of Shp1 in KCL22s cell line resulted in complete phosphorylation of Shp2 both 542 and 580 tyrosine residues and in its reduced sensitivity to the drug, thus supporting the role of this protein in Ima sensitivity. On the other hand, knock-down of Shp2 in KCL22r, that shows low Shp1 level, resulted in growth inhibition, restored Ima sensitivity and is associated to a significant reduction of phosphorylation of both STAT3 (60%) and ERK1/2 (70%). The data on primary cells support the role of Shp1 in Ima resistance in patients. Indeed, we analyzed 60 CML patients classified, according to the ENL definitions, as optimal (n =35), suboptimal (n=17) Ima responder, and primary (n=5) or secondary resistant (n=3) to Ima. The levels of Shp1 mRNA were significantly reduced in resistant patients [ratio of SHP1/ABL 3.2 ± 1.04, (mean±SD), *p<0.05] when compared to the suboptimal (3.8±1.54) and optimal responders (5.8±1.77). Moreover, the Shp1 decrease was observed in CD34+ cells isolated from 6 resistant patients in comparison to 6 optimal responders. In conclusion, our study suggests that an aberrant balance between the Shp1 and 2 levels play a role in the Bcr-Abl independent resistance to Ima through activation of Ras/MAPK pathway and that lower levels of Shp1 are associated with non responsive patients." @default.
- W1504722631 created "2016-06-24" @default.
- W1504722631 creator A5055992704 @default.
- W1504722631 date "2008-12-01" @default.
- W1504722631 modified "2023-09-23" @default.
- W1504722631 title "New Bcr-Abl-independent mechanisms ofresistance to imatinib treatment in chronicmyelogenous leukaemia patients" @default.
- W1504722631 cites W135868982 @default.
- W1504722631 cites W1488372279 @default.
- W1504722631 cites W1490418776 @default.
- W1504722631 cites W1516471608 @default.
- W1504722631 cites W1573399247 @default.
- W1504722631 cites W1640016724 @default.
- W1504722631 cites W1694675716 @default.
- W1504722631 cites W190597540 @default.
- W1504722631 cites W1964339633 @default.
- W1504722631 cites W1966155874 @default.
- W1504722631 cites W1967920366 @default.
- W1504722631 cites W1968172659 @default.
- W1504722631 cites W1968885796 @default.
- W1504722631 cites W1968892414 @default.
- W1504722631 cites W1973720500 @default.
- W1504722631 cites W1978736027 @default.
- W1504722631 cites W1984804608 @default.
- W1504722631 cites W1987403356 @default.
- W1504722631 cites W1987854357 @default.
- W1504722631 cites W1988422991 @default.
- W1504722631 cites W1993948601 @default.
- W1504722631 cites W1994400524 @default.
- W1504722631 cites W1994465394 @default.
- W1504722631 cites W1998593414 @default.
- W1504722631 cites W1999614615 @default.
- W1504722631 cites W2006434892 @default.
- W1504722631 cites W2008228521 @default.
- W1504722631 cites W2013216643 @default.
- W1504722631 cites W2015616444 @default.
- W1504722631 cites W2016086822 @default.
- W1504722631 cites W2016656445 @default.
- W1504722631 cites W2017349699 @default.
- W1504722631 cites W2023969596 @default.
- W1504722631 cites W2025950197 @default.
- W1504722631 cites W2030250764 @default.
- W1504722631 cites W2032164085 @default.
- W1504722631 cites W2033771962 @default.
- W1504722631 cites W2034892057 @default.
- W1504722631 cites W2035910722 @default.
- W1504722631 cites W2036158456 @default.
- W1504722631 cites W2037154482 @default.
- W1504722631 cites W2039731055 @default.
- W1504722631 cites W2043122200 @default.
- W1504722631 cites W2044838118 @default.
- W1504722631 cites W2045510187 @default.
- W1504722631 cites W2051465464 @default.
- W1504722631 cites W2053888362 @default.
- W1504722631 cites W2061860992 @default.
- W1504722631 cites W2064790088 @default.
- W1504722631 cites W2065630930 @default.
- W1504722631 cites W2067652212 @default.
- W1504722631 cites W2070166036 @default.
- W1504722631 cites W2074740152 @default.
- W1504722631 cites W2080411938 @default.
- W1504722631 cites W2082448876 @default.
- W1504722631 cites W2082469361 @default.
- W1504722631 cites W2083261326 @default.
- W1504722631 cites W2083906966 @default.
- W1504722631 cites W2084065981 @default.
- W1504722631 cites W2087430484 @default.
- W1504722631 cites W2089636170 @default.
- W1504722631 cites W2090004346 @default.
- W1504722631 cites W2090681869 @default.
- W1504722631 cites W2092118712 @default.
- W1504722631 cites W2094548766 @default.
- W1504722631 cites W2096003848 @default.
- W1504722631 cites W2096038076 @default.
- W1504722631 cites W2098785293 @default.
- W1504722631 cites W2100418051 @default.
- W1504722631 cites W2101390452 @default.
- W1504722631 cites W2107015590 @default.
- W1504722631 cites W2107425729 @default.
- W1504722631 cites W2114857520 @default.
- W1504722631 cites W2115524556 @default.
- W1504722631 cites W2117569938 @default.
- W1504722631 cites W2127117301 @default.
- W1504722631 cites W2130708019 @default.
- W1504722631 cites W2131174104 @default.
- W1504722631 cites W2132298090 @default.
- W1504722631 cites W2133124453 @default.
- W1504722631 cites W2133683853 @default.
- W1504722631 cites W2137601120 @default.
- W1504722631 cites W2140191827 @default.
- W1504722631 cites W2140899794 @default.
- W1504722631 cites W2145743858 @default.
- W1504722631 cites W2148743957 @default.
- W1504722631 cites W2151486690 @default.
- W1504722631 cites W2153787194 @default.
- W1504722631 cites W2159594827 @default.
- W1504722631 cites W2167829945 @default.
- W1504722631 cites W2207680991 @default.
- W1504722631 cites W2259346194 @default.
- W1504722631 cites W2275311108 @default.
- W1504722631 cites W2318668978 @default.